Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Buy
74
TRVI Quote, Financials, Valuation and Earnings
Last price:
$6.41
Seasonality move
:
16.12%
Day range:
$6.22 - $6.52
52-week range:
$2.30 - $7.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.21x
Volume:
1.2M
Avg. volume:
3.3M
1-year change:
78.27%
Market cap:
$618.8M
Revenue:
--
EPS (TTM):
-$0.47
Earnings Data
Next earnings date for TRVI
May 07
2025
Most recent earnings per share
-$0.11
Beat by $0.01
(Mar 18/2025)
Consensus Estimate
-$0.12
(Mar 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRVI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2025 | Q1 | -- | -- | -- | -$0.12 | -- |
| 03/18/2025 | Q4 | -- | -- | -$0.11 | -$0.12 | $0.01 |
| 11/06/2024 | Q3 | -- | -- | -$0.13 | -$0.11 | -$0.02 |
| 08/08/2024 | Q2 | -- | -- | -$0.12 | -$0.11 | -$0.01 |
| 05/07/2024 | Q1 | -- | -- | -$0.11 | -$0.09 | -$0.02 |
| 03/20/2024 | Q4 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 08/10/2023 | Q2 | -- | -- | -$0.07 | -$0.09 | $0.02 |
| 05/11/2023 | Q1 | -- | -- | -$0.06 | -$0.07 | $0.01 |
| 03/16/2023 | Q4 | -- | -- | -$0.06 | -$0.10 | $0.04 |
| 11/10/2022 | Q3 | -- | -- | -$0.12 | -$0.13 | $0.01 |
| 08/11/2022 | Q2 | -- | -- | -$0.14 | -$0.19 | $0.05 |
| 05/12/2022 | Q1 | -- | -- | -$0.24 | -$0.29 | $0.05 |
| 03/17/2022 | Q4 | -- | -- | -$0.24 | -$0.30 | $0.06 |
| 11/10/2021 | Q3 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 08/12/2021 | Q2 | -- | -- | -$0.49 | -$0.46 | -$0.03 |
| 05/13/2021 | Q1 | -- | -- | -$0.43 | -$0.52 | $0.09 |
| 03/25/2021 | Q4 | -- | -- | -$0.51 | -$0.44 | -$0.07 |
| 11/11/2020 | Q3 | -- | -- | -$0.41 | -$0.51 | $0.10 |
| 08/12/2020 | Q2 | -- | -- | -$0.41 | -$0.48 | $0.07 |
| 05/07/2020 | Q1 | -- | -- | -$0.48 | -$0.44 | -$0.04 |
| 03/16/2020 | Q4 | -- | -- | -$0.37 | -$0.51 | $0.15 |
| 11/14/2019 | Q3 | -- | -- | -$0.41 | -$0.48 | $0.07 |
| 08/12/2019 | Q2 | -- | -- | -$0.41 | -$0.42 | $0.01 |
| 06/13/2019 | Q1 | -- | -- | -- | -$0.52 | -- |
Trevi Therapeutics Earnings Questions
-
How Much did Trevi Therapeutics Generate in Revenue Last Quarter?
Trevi Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Trevi Therapeutics Beat Earnings Last Quarter?
Trevi Therapeutics announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.12 per share.
-
Is Trevi Therapeutics Profitable?
Trevi Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Trevi Therapeutics EPS Next Year?
Trevi Therapeutics's earnings are forecast to decrease from -$0.47 per share to -$0.49 per share next year representing a decrease of -14.19%.
-
When is Trevi Therapeutics's Earnings Date?
Trevi Therapeutics's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is down 28.36% over the past day.
Buy
58
TNXP alert for Mar 25
Tonix Pharmaceuticals Holding [TNXP] is up 32.39% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 17.3% over the past day.
